Wednesday, December 4, 2024
HomeFunding 3Daughters Secures $4.7 Million Oversubscribed Seed Funding

[Funding News] 3Daughters Secures $4.7 Million Oversubscribed Seed Funding

3Daughters, a Evolutionary Healthcare for Women announced successful completion of an oversubscribed Seed funding round of $4.7M. This round included participation from existing investors Thairm Bio, Argosy Foundation, Wexford Science and Technology, LLC, UMass Amherst, and new undisclosed investors. Previously, the company had announced the close of the first tranche of this financing round, exceeding $2 million.

3Daughters, a Evolutionary Healthcare for Women announced successful completion of an oversubscribed Seed funding round of $4.7M. This round included participation from existing investors Thairm Bio, Argosy Foundation, Wexford Science and Technology, LLC, UMass Amherst, and new undisclosed investors. Previously, the company had announced the close of the first tranche of this financing round, exceeding $2 million.

Read also – [Funding News] Element Biosciences Raises Over $277 Million Series D Funding

3Daughters newly designed IUD conforms naturally to a woman’s body and will address the ‘fear factor’, pain and other problems of current IUDs …with no strings attached! Nearly all women use contraception in their lifetimes, and we plan to make it better.

Read also – Infor Acquires Acumen and Albanero

Mary Beth Cicero, CEO of 3Daughters, commented, “We are thrilled by the overwhelming response from both our existing and new investors who share our determination and dedication to improving therapies for women, starting with our advanced IUD and integrated system for insertion and retrieval. Notably, this oversubscribed round supports our preclinical development through an IND filing in early 2025, a major milestone in our development timeline.”

The $8 billion US contraceptive market desperately needs more options and innovation, especially since 275 million women use IUDs globally and use birth control for an average of 30 years. 3Daughters patented inserter and retriever system, in conjunction with our frameless, nonhormonal, magnetic IUD (3D-001), aims to remove the main obstacles that prevent women from selecting one of the most effective forms of birth control. 3Daughters is able to work on addressing these issues because of the funding provided by our investors.

About 3Daughters

Founded in 2021, 3Daughters is a clinical development company focused on Evolutionary Healthcare for Women. Our first evolution is a frameless, magnetic, nonhormonal intrauterine device (IUD) based on physics and geometry for long-acting contraception. Our unique IUD was designed to improve upon the outdated T-shape frame of current IUDs that causes pain, perforation and expulsion. These problems lead to a ‘fear factor’ for women and practitioners inserting the device. Current IUDs also require dangling strings for retrieval- a nuisance factor for women and their partners.

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular